The vaccination has always been in the news for one or the other controversy. As per many medical institutions around the globe, vaccination has always been a positive motivation factor to fight against the covid 19 virus.
Omicron Is A Wake-Up Call For COVID-19 Vaccine Developers
During the month of December when the covid 19 cases were increasing very fastly in the United States due to the increase in the cold weather and Christmas Holidays, vaccination came as a savior for the citizens.
Initially, adults of 65 years and above were eligible to receive vaccination as they were more prone to the novel coronavirus. With the passage of time, the Federal Government expanded the two-dose vaccination eligibility for adults above 18 years.
As per the medical experts, the positive results from the vaccines were tremendous. But during the month of June, a new covid 19 variant was introduced to the world and caused a major outbreak. In the United States, till the end of June 2021, there were 12,000 active cases which spiked more than 4 times creating a panic situation for the citizens and the Government agencies.
Although many health care professionals today have claimed that vaccination was a powerful tool to fight against the delta variant of coronavirus.
The US Centers for Disease Control and Prevention has claimed in their data that till the end of November month, around 60 percent of the American population has been fully vaccinated and 84 percent of the citizens are partially vaccinated, which means the individuals have received at least one dose of the vaccination.
The outbreak news of the Omicron variant on 24 November 2021 was told by the World Health Organization. The medical organizations in the United States started to raise questions about the effectiveness of the Pfizer, Moderna, and Johnson & Johnson vaccination on the Omicron variant.
In a study conducted by various scientists in South Africa and the United States, it has been found that the effectiveness and efficiency of vaccines are diminishing after certain months and it has raised questions on the vaccine manufacturers.
Now some leading immunologists and virologists are very much concerned about the situation and also announced that this is the right time for the vaccine developers in the world to change the strategies and optimize vaccines according to the changing faces of covid 19 virus and from the omicron variant these manufacturers can learn a lot.